XML 26 R15.htm IDEA: XBRL DOCUMENT v3.5.0.1
Employee Stock Compensation
3 Months Ended
Apr. 30, 2016
Share-Based Arrangements With Employees and Nonemployees [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
8.
Employee Stock Compensation
 
The 2012 and 2015 Plans
 
At the Annual Meeting of Stockholders held on July 8, 2015, the Company’s stockholders approved the Lakeland Industries, Inc. 2015 Stock Plan (the “2015 Plan”). The executive officers and all other employees and directors of the Company and its subsidiaries are eligible to participate in the 2015 Plan. The 2015 Plan is currently administered by the compensation committee of the Company’s Board of Directors (“Committee”), except that with respect to all non-employee director awards, the Committee shall be deemed to include the full Board. The 2015 Plan authorizes the issuance of awards of restricted stock, restricted stock units, performance shares, performance units and other stock-based awards. The 2015 Plan also permits the grant of awards that qualify for “performance-based compensation” within the meaning of Section 162(m) of the U.S. Internal Revenue Code. The aggregate number of shares of the Company’s common stock that may be issued under the 2015 Plan may not exceed 100,000 shares. Awards covering no more than 20,000 shares of common stock may be awarded to any plan participant in any one calendar year. Under the 2015 Plan, as of April 30, 2016, the Company granted awards for up to an aggregate of 99,429 restricted shares assuming maximum award levels are achieved.
 
The 2015 Plan, which terminates in July 2017, is the successor to the Company’s 2012 Stock Incentive Plan (the “2012 Plan”). The Company’s 2012 Plan authorized the issuance of up to a maximum of 310,000 shares of the Company’s common stock to employees and directors of the Company and its subsidiaries in the form of restricted stock, restricted stock units, performance shares, performance units and other share-based awards. Under the 2012 Plan, as of April 30, 2016, the Company issued 287,490 fully vested shares of common stock and 8,897 restricted shares which will continue to vest according to the terms of the 2012 Plan.
 
Under the 2012 Plan and the 2015 Plan, the Company generally awards eligible employees and directors with either performance-based or time-based restricted shares. Performance-based restricted shares are awarded at either baseline (target), maximum or zero amounts. The number of restricted shares subject to any award is not tied to a formula or comparable company target ranges, but rather is determined at the discretion of the Committee at the end of the applicable performance period, which is two years under the 2015 Plan and had been three years under the 2012 Plan. The Company recognizes expense related to performance-based restricted share awards over the requisite performance period using the straight-line attribution method based on the most probable outcome (baseline, maximum or zero) at the end of the performance period and the price of the Company’s common stock price at the date of grant.
 
In addition to the performance-based awards, the Company also grants time-based vesting awards which vest either two or three years after date of issuance, subject to continuous employment and certain other conditions. 
 
As of April 30, 2016, unrecognized stock-based compensation expense related to share-based stock awards totaled $8,507 pursuant to the 2012 Plan and $633,241 pursuant to the 2015 Plan, before income taxes, based on the maximum performance award level. Such unrecognized stock-based compensation expense related to restricted stock awards totaled $8,507 for the 2012 Plan and $335,682 for the 2015 Plan at the baseline performance level. The cost of these non-vested awards is expected to be recognized over a weighted-average period of three years for the 2012 Plan and two years for the 2015 Plan. The performance based awards are not considered stock equivalents for earnings per share (“EPS”) calculation purposes.
 
The Company recognized total stock-based compensation costs of $130,443 and $127,652 for the three months ended April 30, 2016 and 2015, respectively, of which $3,795 and $127,652 result from the 2012 Plan, and $126,648 and $0 result from the 2015 Plan. These amounts are reflected in operating expenses. The total income tax benefit recognized for stock-based compensation arrangements was $46,960 and $45,955 for the three- months ended April 30, 2016 and 2015, respectively.
 
Shares under 2015 and 2012 
Stock Plan
 
Outstanding
Unvested Grants
at Maximum at
Beginning of
FY17
Granted during 
FY17 through 
April 30, 2016 
 
Becoming 
Vested during 
FY17 through 
April 30, 
2016
Forfeited 
during 
FY17 through 
April 30, 2016 
 
Outstanding 
Unvested 
Grants at 
Maximum at 
End of 
April 30, 2016
 
Restricted stock grants – employees
 
 
72,999
 
 
 
 
 
 
 
 
72,999
 
Matching award program
 
 
3,000
 
 
 
 
 
 
 
 
3,000
 
Bonus in stock - employees
 
 
2,500
 
 
 
 
 
 
 
 
2,500
 
Retainer in stock - directors
 
 
30,764
 
 
 
 
937
 
 
 
 
29,827
 
Total restricted stock plans
 
 
109,263
 
 
 
 
937
 
 
 
 
108,326
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average grant date fair value
 
$
9.93
 
 
 
$
7.10
 
 
 
$
9.96
 
 
Other Compensation Plans/Programs
 
The Company previously awarded stock-based options to non-employee directors under its Non-employee Directors’ Option Plan (the “Directors’ Plan”) which expired on December 31, 2012. All stock option awards granted under the Directors’ Plan were fully vested at April 30, 2016. During the three-months ending April 30, 2016 there have been zero forfeitures or options exercised, and there were options outstanding to purchase an aggregate of 5,000 shares at a weighted-average exercise price of $8.28 per share. All outstanding stock options have a weighted average remaining contractual term of 0.82 years.
 
The Company currently utilizes a matching award program pursuant to which all employees are entitled to receive one share of restricted stock for each two shares of the Company’s common stock purchased on the open market. Such restricted shares are subject to a one year vesting period. The valuation is based on the stock price at the grant date and is amortized to expense over the vesting period, which approximates the performance period.
 
Pursuant to the Company’s bonus-in-stock program, all employees are eligible to elect to receive any cash bonus in shares of restricted stock. Such restricted shares are subject to a two year vesting period. The valuation is based on the stock price at the grant date and is amortized to expense over the two year period, which approximates the performance period. Since the employee is giving up cash for unvested shares, the amount of shares awarded is 133% of the cash amount based on the stock price at the date of grant.
 
Pursuant to the Company’s director restrictive stock program, all directors are eligible to elect to receive any director fees in shares of restricted stock. Such restricted shares are subject to a two year vesting period. The valuation is based on the stock price at the grant date and is amortized to expense over the two year period, which approximates the performance period. Since the director is giving up cash for unvested shares, the amount of shares awarded is 133% of the cash amount based on the grant date stock price.